Advanced Infusion Systems Market Size, Share, Industry Trends and Forecast to 2030

Market Size & CAGR of Advanced Infusion Systems Market in 2021

The global market size of advanced infusion systems in 2021 was valued at USD 6.75 billion, with a compound annual growth rate (CAGR) of 5.2%. The market is expected to reach a value of USD 9.42 billion by the end of 2021. The increasing prevalence of chronic diseases, technological advancements in infusion systems, and the rising geriatric population are some of the key factors driving the growth of the advanced infusion systems market.

COVID-19 Impact on the Advanced Infusion Systems Market

The COVID-19 pandemic has had a significant impact on the advanced infusion systems market. With the focus on managing the pandemic, there has been a surge in the demand for infusion pumps and systems to administer medications and fluids to COVID-19 patients. The global supply chain disruptions and shortage of essential medical supplies have also affected the market growth. However, the market has shown resilience and adapted to the changing scenario by ramping up production and distribution of infusion systems to meet the increasing demand.

Advanced Infusion Systems Dynamics

The advanced infusion systems market is driven by factors such as the increasing prevalence of chronic diseases, technological advancements in infusion systems, and the rising demand for home healthcare services. Additionally, the growing geriatric population and the need for efficient drug delivery systems are contributing to the market growth. However, factors such as high costs associated with advanced infusion systems and the stringent regulatory requirements may hinder market growth to some extent.

Segments and Related Analysis

The advanced infusion systems market can be segmented based on product type, application, end-user, and region. Product types include infusion pumps, intravenous sets, needleless connectors, and others. Applications of advanced infusion systems include chemotherapy, diabetes management, pain management, and others. End-users of these systems are hospitals, ambulatory surgical centers, homecare settings, and others. Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

By Region Analysis

- North America: The advanced infusion systems market in North America is driven by technological advancements, high healthcare expenditure, and the presence of major market players. - Europe: Europe also holds a significant market share due to the increasing demand for advanced infusion systems in the region. - Asia Pacific: The market in Asia Pacific is expected to witness the fastest growth rate, attributed to the growing healthcare infrastructure and increasing awareness about advanced medical technologies. - Latin America: Latin America is also projected to show substantial growth, supported by the rising prevalence of chronic diseases and improving healthcare facilities. - Middle East & Africa: The market in this region is driven by the increasing investments in healthcare infrastructure and the growing adoption of advanced medical devices.

Key Market Players and Competitive Landscape

Some of the key players in the global advanced infusion systems market include Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Smiths Medical, and Fresenius Kabi. These companies are focusing on strategic partnerships, product innovations, and mergers & acquisitions to strengthen their market position and expand their product portfolio.

Recent happenings in the Advanced Infusion Systems Market

- In June 2021, Becton Dickinson announced the launch of its innovative infusion system designed to improve medication management and patient safety. - In September 2021, ICU Medical completed the acquisition of Smiths Medical to expand its product offerings in the infusion systems market. - In November 2021, Baxter International introduced a new wireless infusion system to enhance patient care and clinical workflow efficiency. - In January 2022, B. Braun Melsungen AG partnered with a leading healthcare technology company to develop a next-generation infusion pump with advanced features for better patient outcomes. - In March 2022, Fresenius Kabi announced the acquisition of a medical device company specializing in advanced infusion technologies to further strengthen its position in the market.